Evaluation of cardiac iron overload in transfusion-dependent adult marrow failure patients by magnetic resonance imaging

Leukemia Research

Volumn 33, Issue 6, 2009, Pages 756-758

  Park, Jinho ^a   Ohyashiki, Kazuma ^a   Akata, Soichi ^a   Takara, Kenichi ^a   Uno, Ritsuko ^a   Kakizaki, Dai ^a   Miyazawa, Keisuke ^a   Kimura, Yukihiko ^a   Tokuuye, Koichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Iron overload; MRI; Myocardial evaluation; Transfusion dependent

Indexed keywords

DEFEROXAMINE; HEMOGLOBIN;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOLOGIC DISEASE; HUMAN; IRON CHELATION; IRON OVERLOAD; MALE; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; SIDEROSIS;

ADULT; AGED; BLOOD TRANSFUSION; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 63349089777     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.10.018     Document Type: Article

References (10)

1. Takatoku M., Uchiyama T., Okamoto S., et al. Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol 78 (2007) 487-494
2. Konen E., Ghoti H., Goitein O., et al. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique. Am J Hematol 82 (2007) 1013-1016
3. Greenberg P.L. Myelodysplastic syndromes: iron overload consequences and current chelating therapies. J Natl Compr Cancer Netw 4 (2006) 91-96
4. Chacko J., Pennell D.J., Tanner M.A., et al. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol 138 (2007) 587-593
5. Jensen P.D., Jensen F.T., Christensen T., et al. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 101 (2003) 4632-4639
6. Di Tucci AA, Matta G, Deplano S, et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 2008;93:1358-8.
7. Anderson L.J., Holden S., Davis B., et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 (2001) 2171-2179
8. Gatterman N. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. Leuk Res Suppl. 3 (2007) S10-S15
9. Suzuki T., Tomonaga M., Miyazaki Y., et al. Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes. Int J Hematol 88 (2008) 30-35
10. Wood J.C., Otto-Duessel M., Gonzalez I., et al. Deferasirox and deferiprone remove cardiac iron in the iron-overload gerbil. Transl Res 148 (2006) 272-280